# Callan JMB Inc.: financial statements, quarterly

CJMB · Nasdaq · CIK 2032545 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cjmb.md) · [Financials](/companies/cjmb/financials.md) · [Filings](/companies/cjmb/filings.md) · [Insiders](/companies/cjmb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cjmb/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,791](/filings/0001641172-25-011061.md) | [1,986](/filings/0001641172-25-024076.md) | [1,435](/filings/0001493152-25-023475.md) | [1,352 d](/filings/0001493152-26-014292.md) | [1,449](/filings/0001493152-26-023708.md) | [1,666](/filings/0001493152-26-038329.md) | [1,447](/filings/0001493152-25-023475.md) | [1,161 d](/filings/0001493152-26-014292.md) | [1,106](/filings/0001493152-26-023708.md) | [1,376](/filings/0001493152-26-038329.md) |
| Cost of revenue | $k | [1,073](/filings/0001641172-25-011061.md) | [1,024](/filings/0001641172-25-024076.md) | [971](/filings/0001493152-25-023475.md) | [933 d](/filings/0001493152-26-014292.md) | [833](/filings/0001493152-26-023708.md) | [1,022](/filings/0001493152-26-038329.md) | [954](/filings/0001493152-25-023475.md) | [806 d](/filings/0001493152-26-014292.md) | [679](/filings/0001493152-26-023708.md) | [618](/filings/0001493152-26-038329.md) |
| Gross profit | $k | [718](/filings/0001641172-25-011061.md) | [962](/filings/0001641172-25-024076.md) | [464](/filings/0001493152-25-023475.md) | [419 d](/filings/0001493152-26-014292.md) | [616](/filings/0001493152-26-023708.md) | [644](/filings/0001493152-26-038329.md) | [493](/filings/0001493152-25-023475.md) | [354 d](/filings/0001493152-26-014292.md) | [427](/filings/0001493152-26-023708.md) | [758](/filings/0001493152-26-038329.md) |
| Selling, general and administrative | $k | [805](/filings/0001641172-25-011061.md) | [1,096](/filings/0001641172-25-024076.md) | [1,245](/filings/0001493152-25-023475.md) | [1,692 d](/filings/0001493152-26-014292.md) | [1,854](/filings/0001493152-26-023708.md) | [2,050](/filings/0001493152-26-038329.md) | [2,372](/filings/0001493152-25-023475.md) | [2,323 d](/filings/0001493152-26-014292.md) | [2,128](/filings/0001493152-26-023708.md) | [2,105](/filings/0001493152-26-038329.md) |
| Operating income | $k | [(87.5)](/filings/0001641172-25-011061.md) | [(133)](/filings/0001641172-25-024076.md) | [(781)](/filings/0001493152-25-023475.md) | [(1,273) d](/filings/0001493152-26-014292.md) | [(1,238)](/filings/0001493152-26-023708.md) | [(1,407)](/filings/0001493152-26-038329.md) | [(1,879)](/filings/0001493152-25-023475.md) | [(2,511) d](/filings/0001493152-26-014292.md) | [(1,701)](/filings/0001493152-26-023708.md) | [(1,347)](/filings/0001493152-26-038329.md) |
| Interest expense | $k | [3.1](/filings/0001641172-25-011061.md) | [1.8](/filings/0001641172-25-024076.md) | [0.5](/filings/0001493152-25-023475.md) | [0.0 d](/filings/0001493152-26-014292.md) | [0.1](/filings/0001493152-26-023708.md) | [0.0 d](/filings/0001493152-26-038329.md) | [0.5](/filings/0001493152-25-023475.md) | [2.1 d](/filings/0001493152-26-014292.md) | not reported | [2.4](/filings/0001493152-26-038329.md) |
| Income tax | $k | [(6.0)](/filings/0001641172-25-011061.md) | [(20.0)](/filings/0001641172-25-024076.md) | [26.0](/filings/0001493152-25-023475.md) | not reported | [4.4](/filings/0001493152-26-023708.md) | [(3.1)](/filings/0001493152-26-038329.md) | [(0.0) d](/filings/0001493152-25-023475.md) | [(4.2) d](/filings/0001493152-26-014292.md) | [0.3](/filings/0001493152-26-023708.md) | [4.8](/filings/0001493152-26-038329.md) |
| Net income | $k | [(81.1)](/filings/0001641172-25-011061.md) | [(112)](/filings/0001641172-25-024076.md) | [(805)](/filings/0001493152-25-023475.md) | [(1,295) d](/filings/0001493152-26-014292.md) | [(1,241)](/filings/0001493152-26-038329.md) | [(1,401)](/filings/0001493152-26-038329.md) | [(2,731)](/filings/0001493152-25-023475.md) | [(2,593) d](/filings/0001493152-26-014292.md) | [(3,215)](/filings/0001493152-26-038329.md) | [(1,232)](/filings/0001493152-26-038329.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001641172-25-011061.md) | [(0.04)](/filings/0001641172-25-024076.md) | [(0.27)](/filings/0001493152-25-023475.md) | not reported | [(0.59)](/filings/0001493152-26-023708.md) | [(0.31)](/filings/0001493152-26-038329.md) | [(0.61)](/filings/0001493152-25-023475.md) | not reported | [(0.32)](/filings/0001493152-26-023708.md) | [(0.22)](/filings/0001493152-26-038329.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001641172-25-011061.md) | [(0.04)](/filings/0001641172-25-024076.md) | [(0.27)](/filings/0001493152-25-023475.md) | not reported | [(0.59)](/filings/0001493152-26-023708.md) | [(0.31)](/filings/0001493152-26-038329.md) | [(0.61)](/filings/0001493152-25-023475.md) | not reported | [(0.32)](/filings/0001493152-26-023708.md) | [(0.22)](/filings/0001493152-26-038329.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [5.2](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | [2.1](/filings/0001493152-26-014292.md) | [5.2](/filings/0001641172-25-011061.md) | [4.2](/filings/0001641172-25-024076.md) | [2.8](/filings/0001493152-25-023475.md) | [2.1](/filings/0001493152-26-038329.md) | [1.4](/filings/0001493152-26-023708.md) | [0.9](/filings/0001493152-26-038329.md) |
| Current assets | $m | not reported | [8.5](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | [3.3](/filings/0001493152-26-014292.md) | [6.8](/filings/0001641172-25-011061.md) | [5.6](/filings/0001641172-25-024076.md) | [4.3](/filings/0001493152-25-023475.md) | [3.1](/filings/0001493152-26-038329.md) | [3.0](/filings/0001493152-26-023708.md) | [1.8](/filings/0001493152-26-038329.md) |
| Total assets | $m | not reported | [9.7](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | [5.1](/filings/0001493152-26-014292.md) | [8.5](/filings/0001641172-25-011061.md) | [9.0](/filings/0001641172-25-024076.md) | [7.7](/filings/0001493152-25-023475.md) | [5.8](/filings/0001493152-26-038329.md) | [5.7](/filings/0001493152-26-023708.md) | [4.5](/filings/0001493152-26-038329.md) |
| Current liabilities | $m | not reported | [0.8](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | [1.3](/filings/0001493152-26-014292.md) | [1.0](/filings/0001641172-25-011061.md) | [1.3](/filings/0001641172-25-024076.md) | [1.2](/filings/0001493152-25-023475.md) | [1.4](/filings/0001493152-26-038329.md) | [1.5](/filings/0001493152-26-023708.md) | [1.4](/filings/0001493152-26-038329.md) |
| Total liabilities | $m | not reported | [0.9](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | [1.9](/filings/0001493152-26-014292.md) | [1.6](/filings/0001641172-25-011061.md) | [3.1](/filings/0001641172-25-024076.md) | [3.6](/filings/0001493152-25-023475.md) | [3.4](/filings/0001493152-26-038329.md) | [4.1](/filings/0001493152-26-023708.md) | [3.8](/filings/0001493152-26-038329.md) |
| Short-term borrowings | $m | not reported | [0.0](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | [0.0](/filings/0001641172-25-001249.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [14.0](/filings/0001641172-25-001249.md) | [8.8](/filings/0001493152-26-014292.md) | [5.2](/filings/0001493152-25-023475.md) | [5.2](/filings/0001493152-25-023475.md) | [4.4](/filings/0001493152-25-023475.md) | [3.2](/filings/0001493152-26-038329.md) | [6.8](/filings/0001493152-26-038329.md) | [5.8](/filings/0001493152-26-038329.md) | [4.2](/filings/0001493152-25-023475.md) | [2.3](/filings/0001493152-26-038329.md) | [1.6](/filings/0001493152-26-038329.md) | [0.7](/filings/0001493152-26-038329.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [6.8](/filings/0001641172-25-011061.md) | [269 d](/filings/0001641172-25-024076.md) | [988 d](/filings/0001493152-25-023475.md) | [(723) d](/filings/0001493152-26-014292.md) | [(1,562)](/filings/0001493152-26-023708.md) | [(563) d](/filings/0001493152-26-038329.md) | [(1,763) d](/filings/0001493152-25-023475.md) | [(659) d](/filings/0001493152-26-014292.md) | [(1,680)](/filings/0001493152-26-023708.md) | [(396) d](/filings/0001493152-26-038329.md) |
| Capital expenditure | $k | [44.7](/filings/0001641172-25-011061.md) | [1.2 d](/filings/0001641172-25-024076.md) | [0.3 d](/filings/0001493152-25-023475.md) | [0.0 d](/filings/0001493152-26-014292.md) | [15.0](/filings/0001493152-26-023708.md) | [433 d](/filings/0001493152-26-038329.md) | [169 d](/filings/0001493152-25-023475.md) | [0.0 d](/filings/0001493152-26-014292.md) | [35.3](/filings/0001493152-26-023708.md) | [34.2 d](/filings/0001493152-26-038329.md) |
| Dividends paid | $k | [3,382](/filings/0001641172-25-011061.md) | [0.0 d](/filings/0001641172-25-024076.md) | [(0.0) d](/filings/0001493152-25-023475.md) | [(54.0) d](/filings/0001493152-26-014292.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [2,500](/filings/0001641172-25-011061.md) | [3,000](/filings/0001641172-25-024076.md) | [3,000](/filings/0001493152-25-023475.md) | [5,454](/filings/0001493152-26-023708.md) | [4,457](/filings/0001493152-26-038329.md) | [4,490](/filings/0001493152-25-023475.md) | [3,863](/filings/0001493152-26-023708.md) | [5,646](/filings/0001493152-26-038329.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,752,368 at 2026-08-12, from the cover of the [10-Q filed 2026-08-14](/filings/0001493152-26-038329.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.